Skip to main content
Glama

Search iRES Enforcement

fda_ires_enforcement
Read-onlyIdempotent

Search iRES enforcement recalls with cross-references to openFDA enforcement data. Filter by company name (fuzzy match), recall number, product type (e.g., Drugs, Devices), or date range. Returns detailed recall info including event classification, product codes, and quantities. Related: fda_search_enforcement (openFDA recall data), fda_recall_facility_trace (trace recall to manufacturing facility).

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
limitNoMax results to return (1-500)
offsetNoResult offset for pagination
date_toNoEnd date for enforcement_report_date range (YYYY-MM-DD)
date_fromNoStart date for enforcement_report_date range (YYYY-MM-DD)
company_nameNoCompany name (fuzzy match)
product_typeNoProduct type (e.g. Drugs, Devices)
recall_numberNoRecall number

TDQS

A4.2/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true and idempotentHint=true, covering safety. The description adds meaningful context by explaining the cross-referencing behavior and what the response includes (event classification, product codes, quantities), which goes beyond the annotations without contradicting them.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is three sentences with the core purpose in the first sentence, filter details in the second, and return/related tools in the third. Every sentence earns its place, and the structure is front-loaded and scannable.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a search tool with 7 parameters and no output schema, the description covers the main purpose, filters, return content, and related tools. It does not explicitly mention pagination, but the schema documents limit/offset. Overall, it provides enough context for an agent to invoke correctly, with minor gaps around usage constraints.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

All 7 parameters have schema descriptions (100% coverage), so the baseline is 3. The description's filter list ('company name (fuzzy match), recall number, product type, date range') mostly restates the schema, though it does add product type examples. It does not provide additional semantic clarification beyond what the schema already offers.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description begins with the specific action 'Search iRES enforcement recalls' and immediately distinguishes from siblings by noting cross-references to openFDA enforcement data and naming related tools. This gives a clear verb+resource+scope that is distinct from similar tools like fda_search_enforcement.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides related tools as alternatives (fda_search_enforcement, fda_recall_facility_trace) and lists filter dimensions that suggest use cases. However, it lacks explicit 'use when' or 'not when' guidance, leaving the user to infer the best context from the alternatives.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.1/5.0
Disambiguation4/5

Most tools have distinct purposes with clear boundaries, such as fda_search_drugs for drug applications and fda_search_510k for device clearances. However, some overlap exists, like fda_device_udi and fda_device_udi_lookup both querying UDI data, which could cause confusion despite differences in scope.

Naming Consistency5/5

All tool names follow a consistent snake_case pattern with a clear fda_ prefix, using descriptive verbs like search, get, list, and link. This uniformity makes the set predictable and easy to navigate, with no deviations in naming style.

Tool Count2/5

With 48 tools, the count is excessive for a single server, making it overwhelming and difficult for agents to manage. While the domain is broad (FDA data), the toolset feels bloated with many specialized or overlapping tools that could be consolidated.

Completeness5/5

The toolset provides comprehensive coverage of FDA data domains, including drugs, devices, inspections, compliance, recalls, and facilities. It supports full CRUD-like operations (e.g., search, get, link, save) and lifecycle workflows, with no obvious gaps for the intended purpose.

Resources